Primed Stem Cells Combat Schistosomiasis Fibrosis via Itgb2-Rac1
In a groundbreaking study poised to revolutionize the therapeutic strategies for schistosomiasis-associated fibrosis, researchers have unveiled a novel mechanism by which primed mesenchymal stem cells (MSCs) orchestrate the attenuation of fibrotic progression....
Read moreDetails

